Ignoring Hydration Many side effects improve dramatically when hydration improves
While these medications don't directly stimulate energy production, many patients report feeling more energetic through improved blood sugar control and weight loss
Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial
Publication Details Paper Title: Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation | Authors: Huilin Tang, Bingyu Zhang, Yiwen Lu, Dazheng Zhang, Ruishan Liu, Yuan Lu, George Cotsarelis, David A
On the basis of results of the most recent CVOTs (DAPA-HF, DAPA-CKD, EMPEROR-R), the FDA has approved dapagliflozin (2020) and empagliflozin (2021) to reduce risk for CV death and HF hospitalization in adults with HF and reduced ejection fraction regardless of whether they have diabetes [24, 25]
JHEP Rep